Literature DB >> 32014916

Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.

Shuichi Iwahasi1, Feng Rui2, Yuji Morine2, Shinichiro Yamada2, Y U Saito2, Tetsuya Ikemoto2, Satoru Imura2, Mitsuo Shimada2.   

Abstract

BACKGROUND/AIM: The hepatic stellate cells (HSCs) have relationship to cancer progression. The aim of this study is to investigate the effect of HSCs and the role of IL-6/Stat3 pathway on hepatocellular carcinoma (HCC) progression.
MATERIALS AND METHODS: HCCs were co-cultured with HSCs. The viability and migration ability of cancer cells were detected. Epithelial-mesenchymal transition (EMT) marker (E-cadherin), stem cell marker (CD44) and p-signal transducer and activator of transcription 3 (p-STAT3) of cancer cells were evaluated. Finally, interleukin-6 (IL-6) neutralization was performed.
RESULTS: Co-culture of HCCs with HSCs increased cancer cell viability and migration ability. EMT and stemness of cancer cells increased with HSCs. Following IL-6 neutralization, phospho-STAT3 activation, cancer cell viability and migration, as well as EMT, and stemness of cancer cells decreased.
CONCLUSION: HSCs promoted HCC progression through the IL-6/STAT3 pathway. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; hepatic stellate cell; interleukin-6

Mesh:

Substances:

Year:  2020        PMID: 32014916     DOI: 10.21873/anticanres.14005

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Development of quantum dot-based fluorescence lateral flow immunoassay strip for rapid and quantitative detection of serum interleukin-6.

Authors:  Jinsong Tang; Lili Wu; Jingtao Lin; Erying Zhang; Yong Luo
Journal:  J Clin Lab Anal       Date:  2021-03-24       Impact factor: 2.352

2.  IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells.

Authors:  Yu Li; Gang Chen; Zhijian Han; Huijuan Cheng; Liang Qiao; Yumin Li
Journal:  Onco Targets Ther       Date:  2020-09-30       Impact factor: 4.345

3.  The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment.

Authors:  Yuma Wada; Kazunori Tokuda; Yuji Morine; Shohei Okikawa; Shoko Yamashita; Tetsuya Ikemoto; Satoru Imura; Yu Saito; Shinichiro Yamada; Mitsuo Shimada
Journal:  Oncotarget       Date:  2020-12-08

4.  DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Yiwen Guo; Weixin Luo; Shanzhou Huang; Wenting Zhao; Huadi Chen; Yihao Ma; Maodong Ye; Yu Nie; Yixi Zhang; Changjun Huang; Qi Zhou; Xiaoshun He; Maogen Chen
Journal:  J Hepatocell Carcinoma       Date:  2021-08-03

Review 5.  IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma.

Authors:  Junnv Xu; Haifeng Lin; Gang Wu; Mingyue Zhu; Mengsen Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

Review 6.  Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances.

Authors:  Blanca Cucarull; Anna Tutusaus; Patricia Rider; Tania Hernáez-Alsina; Carlos Cuño; Pablo García de Frutos; Anna Colell; Montserrat Marí; Albert Morales
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

7.  Blue light irradiation inhibits the growth of colon cancer and activation of cancer‑associated fibroblasts.

Authors:  Toshiaki Yoshimoto; Mitsuo Shimada; Takuya Tokunaga; Toshihiro Nakao; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Yuma Wada; Shohei Okikawa; Kozo Yoshikawa
Journal:  Oncol Rep       Date:  2022-04-13       Impact factor: 3.906

8.  Clinical Analysis of Echocardiography and Serum IL-6 and TNF-α Changes in Pregnant Women with Hypertension.

Authors:  Ying Liu; Xiaolin Hou; Mei Yu; Jin Zhou
Journal:  Scanning       Date:  2022-08-30       Impact factor: 1.750

9.  HIF-1α expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasis.

Authors:  Yuma Wada; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Yu Saito; Chie Takasu; Shinichiro Yamada; Mitsuo Shimada
Journal:  World J Surg Oncol       Date:  2020-09-07       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.